Showing results (1521-1530 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|April 21, 2001
A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell graftsS Serke, H E JohnsenBone Marrow Transplantation|April 21, 2001
Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumorsG Reich, M Y Mapara, P Reichardt, et al.Bone Marrow Transplantation|April 21, 2001
Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipientsC J Graber, K N de Almeida, J C Atkinson, et al.Bone Marrow Transplantation|April 21, 2001
Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemiaU Platzbecker, C Thiede, J Freiberg-Richter, et al.Bone Marrow Transplantation|April 21, 2001
Successful engraftment of a second transplant using non-myeloablative conditioning as treatment for graft failure following unrelated donor BMTJ L Byrne, C Musuka, B Davy, et al.Bone Marrow Transplantation|April 21, 2001
Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literatureL Mileshkin, H M Prince, D Rischin, et al.Bone Marrow Transplantation|December 7, 2000
Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplantsJ R Passweg, T Kühne, M Gregor, et al.Bone Marrow Transplantation|December 7, 2000
High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility studyG Meloni, S Capria, S Trasarti, et al.Bone Marrow Transplantation|December 7, 2000
Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survivalE González-Barca, A Fernández de Sevilla, A Domingo-Claros, et al.Bone Marrow Transplantation|December 7, 2000
Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell TransplantationK Matsuo, N Hamajima, Y Morishima, et al.Pageof 993